These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 34970923)

  • 1. Effective Study: Development and Application of a Question-Driven, Time-Effective Cardiac Magnetic Resonance Scanning Protocol.
    Torlasco C; Castelletti S; Soranna D; Volpato V; Figliozzi S; Menacho K; Cernigliaro F; Zambon A; Kellman P; Moon JC; Badano LP; Parati G
    J Am Heart Assoc; 2022 Jan; 11(1):e022605. PubMed ID: 34970923
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Does stress perfusion imaging improve the diagnostic accuracy of late gadolinium enhanced cardiac magnetic resonance for establishing the etiology of heart failure?
    Gulsin GS; Shetye A; Khoo J; Swarbrick DJ; Levelt E; Lai FY; Squire IB; Arnold JR; McCann GP
    BMC Cardiovasc Disord; 2017 Apr; 17(1):98. PubMed ID: 28390413
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiac magnetic resonance T1 mapping. Part 2: Diagnostic potential and applications.
    Reiter U; Reiter C; Kräuter C; Fuchsjäger M; Reiter G
    Eur J Radiol; 2018 Dec; 109():235-247. PubMed ID: 30539759
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The diagnostic value of quantitative imaging for acute myocardial infarction].
    Cui Q; Yu J; Ge X; Gao G; Liu Y; He Q; Cui Q; Wang H; Shen A
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2022 Feb; 34(2):178-182. PubMed ID: 35387725
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Role and Advantages of Cardiac Magnetic Resonance in the Diagnosis of Myocardial Ischemia.
    Silva TQAC; Pezel T; Jerosch-Herold M; Coelho-Filho OR
    J Thorac Imaging; 2023 Jul; 38(4):235-246. PubMed ID: 36917509
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of fully automated myocardial segmentation techniques in native and contrast-enhanced T1-mapping cardiovascular magnetic resonance images using fully convolutional neural networks.
    Farrag NA; Lochbihler A; White JA; Ukwatta E
    Med Phys; 2021 Jan; 48(1):215-226. PubMed ID: 33131085
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiac Magnetic Resonance Tissue Characterization in Ischemic Cardiomyopathy.
    Muscogiuri G; Ricci F; Scafuri S; Guglielmo M; Baggiano A; De Stasio V; Di Donna C; Spiritigliozzi L; Chiocchi M; Lee SJ; De Cecco CN; van Assen M; Rabbat MG; Pontone G
    J Thorac Imaging; 2022 Jan; 37(1):2-16. PubMed ID: 34524203
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Advanced myocardial tissue characterisation by a multi-component CMR protocol in patients with rheumatoid arthritis.
    Greulich S; Mayr A; Kitterer D; Latus J; Henes J; Vecchio F; Kaesemann P; Patrascu A; Greiser A; Groeninger S; Romeo F; Braun N; Alscher MD; Sechtem U; Mahrholdt H
    Eur Radiol; 2017 Nov; 27(11):4639-4649. PubMed ID: 28500368
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic Benefit of Cardiac Magnetic Resonance Over Transthoracic Echocardiography for the Assessment of Ischemic and Nonischemic Dilated Cardiomyopathy Patients Referred for the Evaluation of Primary Prevention Implantable Cardioverter-Defibrillator Therapy.
    Pontone G; Guaricci AI; Andreini D; Solbiati A; Guglielmo M; Mushtaq S; Baggiano A; Beltrama V; Fusini L; Rota C; Segurini C; Conte E; Gripari P; Dello Russo A; Moltrasio M; Tundo F; Lombardi F; Muscogiuri G; Lorenzoni V; Tondo C; Agostoni P; Bartorelli AL; Pepi M
    Circ Cardiovasc Imaging; 2016 Oct; 9(10):. PubMed ID: 27729359
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnostic value of the novel CMR parameter "myocardial transit-time" (MyoTT) for the assessment of microvascular changes in cardiac amyloidosis and hypertrophic cardiomyopathy.
    Chatzantonis G; Bietenbeck M; Florian A; Meier C; Stalling P; Korthals D; Reinecke H; Yilmaz A
    Clin Res Cardiol; 2021 Jan; 110(1):136-145. PubMed ID: 32372287
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical application of cardiac CMR.
    Al-Mallah M; Kwong RY
    Rev Cardiovasc Med; 2009; 10(3):134-41. PubMed ID: 19898290
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical Validation of a 3-Dimensional Ultrafast Cardiac Magnetic Resonance Protocol Including Single Breath-Hold 3-Dimensional Sequences.
    Gómez-Talavera S; Fernandez-Jimenez R; Fuster V; Nothnagel ND; Kouwenhoven M; Clemence M; García-Lunar I; Gómez-Rubín MC; Navarro F; Pérez-Asenjo B; Fernández-Friera L; Calero MJ; Orejas M; Cabrera JA; Desco M; Pizarro G; Ibáñez B; Sánchez-González J
    JACC Cardiovasc Imaging; 2021 Sep; 14(9):1742-1754. PubMed ID: 33865783
    [TBL] [Abstract][Full Text] [Related]  

  • 13. T(1) mapping for the diagnosis of acute myocarditis using CMR: comparison to T2-weighted and late gadolinium enhanced imaging.
    Ferreira VM; Piechnik SK; Dall'Armellina E; Karamitsos TD; Francis JM; Ntusi N; Holloway C; Choudhury RP; Kardos A; Robson MD; Friedrich MG; Neubauer S
    JACC Cardiovasc Imaging; 2013 Oct; 6(10):1048-1058. PubMed ID: 24011774
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic Cardiac Magnetic Resonance Markers of Left Ventricular Involvement in Arrhythmogenic Cardiomyopathy for Predicting Heart Failure Outcomes.
    Chun KH; Oh J; Hong YJ; Yu HT; Lee CJ; Kim TH; Joung B; Pak HN; Lee MH; Kim YJ; Kang SM
    J Am Heart Assoc; 2022 Mar; 11(6):e023167. PubMed ID: 35261277
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adenosine Stress and Rest T1 Mapping Can Differentiate Between Ischemic, Infarcted, Remote, and Normal Myocardium Without the Need for Gadolinium Contrast Agents.
    Liu A; Wijesurendra RS; Francis JM; Robson MD; Neubauer S; Piechnik SK; Ferreira VM
    JACC Cardiovasc Imaging; 2016 Jan; 9(1):27-36. PubMed ID: 26684978
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Contemporary Application of Cardiovascular Magnetic Resonance Imaging.
    Han Y; Chen Y; Ferrari VA
    Annu Rev Med; 2020 Jan; 71():221-234. PubMed ID: 31986088
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostic Accuracy of CMR With Late Gadolinium Enhancement for Ischemic Cardiomyopathy: A Systematic Review and Meta-Analysis.
    Papanastasiou CA; Kampaktsis PN; Bazmpani MA; Zegkos T; Efthimiadis G; Tsapas A; Ziakas A; Karamitsos TD
    JACC Cardiovasc Imaging; 2023 Mar; 16(3):399-401. PubMed ID: 36889852
    [No Abstract]   [Full Text] [Related]  

  • 18. Diffuse Myocardial Fibrosis and Inflammation in Rheumatoid Arthritis: Insights From CMR T1 Mapping.
    Ntusi NAB; Piechnik SK; Francis JM; Ferreira VM; Matthews PM; Robson MD; Wordsworth PB; Neubauer S; Karamitsos TD
    JACC Cardiovasc Imaging; 2015 May; 8(5):526-536. PubMed ID: 25890584
    [TBL] [Abstract][Full Text] [Related]  

  • 19. T-wave and its association with myocardial fibrosis on cardiovascular magnetic resonance examination.
    Zareba KM; Truong VT; Mazur W; Smart SM; Xia X; Couderc JP; Raman SV
    Ann Noninvasive Electrocardiol; 2021 Mar; 26(2):e12819. PubMed ID: 33336876
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiac magnetic resonance including parametric mapping in acute Takotsubo syndrome: Preliminary findings.
    Dabir D; Luetkens J; Kuetting DLR; Feisst A; Isaak A; Schild HH; Thomas D
    Eur J Radiol; 2019 Apr; 113():217-224. PubMed ID: 30927950
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.